123 related articles for article (PubMed ID: 8384071)
21. Preliminary results of bladder-preserving therapy with definitive radiotherapy and intraarterial infusion of chemotherapy.
Tsujii H; Akaza H; Ohtani M; Miyanaga N; Shimazoi T; Uchida K; Koiso K; Tsuji H; Okumura T; Ohara K
Strahlenther Onkol; 1994 Sep; 170(9):531-7. PubMed ID: 7940124
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant systemic chemotherapy after complete transurethral resection of superficially invasive bladder carcinoma (T1 G3-4 and T2 G2-4).
Rübben H; Weissbach L; Knebel L; Deutz FJ; Giani G; Graf-Dobberstein C; Gebhard R
Urol Int; 1990; 45(2):78-83. PubMed ID: 2184564
[TBL] [Abstract][Full Text] [Related]
23. [Pelvic lymph node metastasis from bladder cancer markedly responsive to methotrexate vinblastine doxorubicin and cisplatin (M-VAC) therapy followed by radiotherapy: a case report].
Hatano K; Kawashima A; Arai Y; Inoue H; Miyagawa Y; Takaha N; Nishimura K; Miyake O; Okuyama A
Hinyokika Kiyo; 2006 Oct; 52(10):801-3. PubMed ID: 17131872
[TBL] [Abstract][Full Text] [Related]
24. Combined treatment of invasive bladder carcinoma with transurethral resection, induction chemotherapy, and radical radiotherapy plus concomitant protracted infusion of cisplatin and 5-fluorouracil: a phase I study.
Danesi DT; Arcangeli G; Cruciani E; Mecozzi A; Saracino B; Giacobini S; Pannunzio E; Biggio A; Orefici F
Cancer; 1997 Oct; 80(8):1464-71. PubMed ID: 9338471
[TBL] [Abstract][Full Text] [Related]
25. A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer.
Zietman AL; Shipley WU; Kaufman DS; Zehr EM; Heney NM; Althausen AF; McGovern FJ
J Urol; 1998 Nov; 160(5):1673-7. PubMed ID: 9783929
[TBL] [Abstract][Full Text] [Related]
26. [Neoadjuvant chemotherapy for invasive bladder cancer].
Kageyama Y; Kihara K
Gan To Kagaku Ryoho; 2001 Nov; 28(12):1838-44. PubMed ID: 11729476
[TBL] [Abstract][Full Text] [Related]
27. Standard or accelerated methotrexate, vinblastine, doxorubicin and cisplatin as neoadjuvant chemotherapy for locally advanced urothelial bladder cancer: Does dose intensity matter?
Pouessel D; Chevret S; Rolland F; Gravis G; Geoffrois L; Roubaud G; Terrisse S; Boyle H; Chevreau C; Dauba J; Moriceau G; Alexandre I; Deplanque G; Chapelle A; Vauleon E; Colau A; Audenet F; Grellety T; Culine S
Eur J Cancer; 2016 Feb; 54():69-74. PubMed ID: 26724422
[TBL] [Abstract][Full Text] [Related]
28. Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03.
Shipley WU; Winter KA; Kaufman DS; Lee WR; Heney NM; Tester WR; Donnelly BJ; Venner PM; Perez CA; Murray KJ; Doggett RS; True LD
J Clin Oncol; 1998 Nov; 16(11):3576-83. PubMed ID: 9817278
[TBL] [Abstract][Full Text] [Related]
29. Combined intraarterial chemotherapy and radiotherapy in the treatment of bladder carcinoma.
Mokarim A; Uetani M; Hayashi N; Sakamoto I; Minami K; Ogawa Y; Ochi M; Matsuoka Y; Hayashi K; Nomata K
Cancer; 1997 Nov; 80(9):1776-85. PubMed ID: 9351547
[TBL] [Abstract][Full Text] [Related]
30. Induction cisplatin and fluorouracil-based chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer.
Lin CC; Hsu CH; Cheng JC; Huang CY; Tsai YC; Hsu FM; Huang KH; Cheng AL; Pu YS
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):442-8. PubMed ID: 19307067
[TBL] [Abstract][Full Text] [Related]
31. [Neoadjuvant and adjuvant chemotherapy of bladder cancer].
Kuroda M; Kotake T
Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():362-9. PubMed ID: 7986116
[TBL] [Abstract][Full Text] [Related]
32. Rapidly alternating chemotherapy and radiotherapy instead of cystectomy for the treatment of muscle-invasive carcinoma of the urinary bladder: long term results of a pilot study.
Vikram B; Chadha M; Malamud SC; Hecht H; Grabstald H
Cancer; 1998 Mar; 82(5):918-22. PubMed ID: 9486582
[TBL] [Abstract][Full Text] [Related]
33. Chemoradiotherapy for muscle invading bladder carcinoma. Final report of a single institutional organ-sparing program.
Droller MJ
J Urol; 2002 May; 167(5):2297-8. PubMed ID: 11956495
[No Abstract] [Full Text] [Related]
34. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer.
Freiha F; Reese J; Torti FM
J Urol; 1996 Feb; 155(2):495-9; discussion 499-500. PubMed ID: 8558644
[TBL] [Abstract][Full Text] [Related]
35. [Small cell carcinoma of the urinary bladder: a case report].
Yamada T; Kamei S; Miwa K; Nishida Y; Takahashi Y; Deguchi T
Hinyokika Kiyo; 2000 Jul; 46(7):475-7. PubMed ID: 10965454
[TBL] [Abstract][Full Text] [Related]
36. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder.
Blick C; Hall P; Pwint T; Al-Terkait F; Crew J; Powles T; Macaulay V; Munro N; Douglas D; Kilbey N; Protheroe A; Chester JD
Cancer; 2012 Aug; 118(16):3920-7. PubMed ID: 22614698
[TBL] [Abstract][Full Text] [Related]
37. [Organ preservation in bladder carcinoma by chemotherapy and TUR].
Dunst J
Strahlenther Onkol; 1999 Feb; 175(2):86-7. PubMed ID: 10065146
[No Abstract] [Full Text] [Related]
38. [Systemic chemotherapy in advanced bladder cancer. New aspects].
Jakse G
Wien Klin Wochenschr; 1987 Jan; 99(2):54-7. PubMed ID: 3564487
[TBL] [Abstract][Full Text] [Related]
39. Curative radiotherapy following chemotherapy for invasive bladder carcinoma (a preliminary report).
Farah R; Chodak GW; Vogelzang NJ; Awan AM; Quiet CA; Moormeier J; Schoenberg H; Weichselbaum RR
Int J Radiat Oncol Biol Phys; 1991 Mar; 20(3):413-7. PubMed ID: 1995525
[TBL] [Abstract][Full Text] [Related]
40. Treatment of Small Cell Carcinoma of the Bladder With Chemotherapy and Radiation after Transurethral Resection of a Bladder Tumor.
Bryant CM; Dang LH; Stechmiller BK; Gilbert SM; Morris CG; Zlotecki RA
Am J Clin Oncol; 2016 Feb; 39(1):69-75. PubMed ID: 24517956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
